Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,950 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?
Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, Khan A, Burman WJ; Tuberculosis Trials Consortium. Jasmer RM, et al. Among authors: khan a. Am J Respir Crit Care Med. 2004 Dec 15;170(12):1360-6. doi: 10.1164/rccm.200408-1081OC. Epub 2004 Oct 11. Am J Respir Crit Care Med. 2004. PMID: 15477492 Clinical Trial.
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.
Burman W, Benator D, Vernon A, Khan A, Jones B, Silva C, Lahart C, Weis S, King B, Mangura B, Weiner M, El-Sadr W; Tuberculosis Trials Consortium. Burman W, et al. Among authors: khan a. Am J Respir Crit Care Med. 2006 Feb 1;173(3):350-6. doi: 10.1164/rccm.200503-417OC. Epub 2005 Aug 18. Am J Respir Crit Care Med. 2006. PMID: 16109981 Clinical Trial.
Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA; Tuberculosis Trials Consortium. Benator DA, et al. Among authors: khan ae. Pharmacotherapy. 2007 Jun;27(6):793-800. doi: 10.1592/phco.27.6.793. Pharmacotherapy. 2007. PMID: 17542762 Clinical Trial.
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, Lahart C, Metchock B, Pachucki C, Stanton L, Vernon A, Villarino ME, Wang YC, Weiner M, Weis S; Tuberculosis Trials Consortium. Benator D, et al. Among authors: khan a. Lancet. 2002 Aug 17;360(9332):528-34. doi: 10.1016/s0140-6736(02)09742-8. Lancet. 2002. PMID: 12241657 Clinical Trial.
21,950 results
You have reached the last available page of results. Please see the User Guide for more information.